DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Gonzales D, Rennard SI, Nides M. et al.
Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs. sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial.
Jama 2006; 296: 47-55
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.